Abstract-One of the major challenges in the design of a new class of medical device is ensuring that the device will have a safe and effective user interface for the intended users. Human Factors Engineering addresses these concerns through direct study of how a user interacts with newly designed devices with unique features. In this study, a novel long duration, low intensity therapeutic ultrasound device is tested by 20 end users representative of the intended user population. Over 90% of users were able to operate the device successfully. The therapeutic ultrasound device was found to be reasonably safe and effective for the intended users, uses, and use environments.
I. INTRODUCTION
Therapeutic ultrasound has been used to treat pain associated with musculoskeletal conditions and increase local blood flow in soft tissues for the past 60 years. The skill required to apply the treatment properly, along with the cost and size of the equipment, has confined ultrasound to the practitioner's office. As a result, treatments are typically applied once or twice a week for 5-15 minutes [1, 2] . These factors have limited the therapeutic potential of ultrasound, which research has shown is more effective when ultrasound is applied more frequently or for longer durations. Recently, long duration, low intensity therapeutic ultrasound has demonstrated an ability to maintain joint cartilage and modify osteoarthritis in animal models [3, 4] , as well as treat tendinopathies [5] . Advances in piezoelectric technology have enabled a miniaturization of therapeutic ultrasound technology. As a result, it is now possible for an ultrasound therapy system to be wearable and self-applied by an end user e.g. the patient themselves. Under the care of a physician, such a device has been used to relieve muscle spasm [6] , treat tendinopathy [7] , and reduce pain associated with osteoarthritis [8] . While there is significant potential for such a technology to provide a non-pharmaceutical alternative to pain relief, the device must account for how a non-professional user will handle the product. These studies, called Human Factors Engineering (HFE), represent a significant portion of designing a new medical device and ensuring it is optimally designed for the intended users and use case scenarios. This work describes an IRB-approved Research reported in this publication was supported by the National Institute On Minority Health And Health Disparities of the National Institutes of Health under Award Number R43MD008597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also supported by the Connecticut Innovations Talent Bridge Program.
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clinical study conducted to ascertain the degree of usability of a new medical device from the perspective of the end-user who self-administered the device away from the practitioner's office.
A. Therapeutic Device and User Interface
The therapeutic device, called sam® (subsequently referred to as the therapeutic ultrasound device), is a portable, wearable ultrasound device (Figure 1 ). It is currently FDAcleared for stationary application for up to four hours. The device is comprised of three components: a power controller, an ultrasound transducer (applicator), and a coupling bandage. The power controller consists of the operator interface, timing circuit and battery for the device. The applicator generates a high frequency signal and converts the electric energy to acoustic driver energy at 98% efficiency [9, 10] . The coupling bandage consists of a non-woven fabric coated with a medical grade adhesive, a plastic interlock that secures the ultrasound transducer to the body, and a reservoir of coupling medium that acts as a conduit for the ultrasound signal. Prior to use, the device must be charged through a micro-USB port. The device is capable of delivering continuous 132 mW/cm 2 ultrasound at 3 MHz for treatment intervals up to four hours.
The user experience when using the device starts by connecting the applicator to the power controller by use of a cable with a special luer-lock fitting. The user then clips the applicator into the coupling bandage and applies it to the body in the treatment location. The device is operated through an interface on the power controller. There is a Figure 1 : The therapeutic ultrasound system tested. On the left is the ultrasound transducer attached to a bandage. On the right is the power controller, which contains the user interface.
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large central power button which activates the device. There is a toggle switch to set the treatment time, and there is a lock switch to prevent the treatment time from changing inadvertently during use.
During design development, several Human Factors Engineering concepts were taken into consideration. The user interface was minimized to two buttons and a switch, in order to simplify operation. The power button was placed in the center of the device, and is thumb sized. The time-toggle switch is located for easy actuation with the thumb when the device is held in the right hand. The applicator was designed to have less than a 1.5 cm standoff above the skin, to maximize the comfort associated with wearing the device.
II. PROCEDURES
A. Subject selection and enrollment Twenty subjects completed this IRB-approved study (Schulman IRB #201307896). This sample size was chosen based on FDA guidance on human factors research [11, 12] . Eligible subjects were 18 years of age or older, with the ability to read, write, and speak English. Individuals were excluded if they had a condition that is contraindicated for ultrasound therapy. Subjects were recruited through flyers, provided informed consent, and enrolled in the study. They would then receive a short (approximately 10 minute) demonstration on how to apply and operate the device.
B. Study Treatments
The therapeutic ultrasound device was the intervention method in the study. This device has an operation mode with one ultrasound transducer and an operation mode with two ultrasound transducers. Subjects were asked to use the device three times within a seven day period, each time for a four-hour treatment duration. For their first treatment, the subjects were asked to use the device with one ultrasound transducer. For the second treatment, the subjects were asked to use the device with two ultrasound transducers. During the third treatment, subjects were free to use the device in either operation mode. After each treatment, subjects were asked to fill out a usability feedback survey.
C. Subject Surveys
Subjects were asked to fill out a 27 point questionnaire that assessed how the device was used, where it was applied, the ease of use, whether the device operated successfully for the duration of treatment, and a discussion of any issues that may have been encountered while using the device. The complete survey, along with a summary of subjects' responses to each question, is shown in Table 1 . All twenty subjects completed the study successfully. The complete results, along with the questions, are shown in Table 1 . Most importantly, no subjects reported an adverse event or experienced any skin damage from 4-hour treatments with the device. Nearly all subjects were able to successfully operate the device (95%) and thought the device was easy to use (93%) (Figure 2) . Additionally, 90% of users had a positive experience overall, and 87% of users would use the device again. The primary constructive feedback related to the device was that the coupling medium was messy, and that there were difficulties with the interlock between the ultrasound transducer and the bandage containing the coupling medium, both in making the connection and in breaking the connection after use.
A small fraction of uses (8%) were followed by the subject saying that the applicator got too hot during the treatment, but only a third of them (3%) reported discomfort due to the heat. Other reported causes of discomfort were that the bandage was irritating to the skin (3%) and that the device vibrated too much (5%), which indicated the activation of a safety feature. Following treatment, subjects described their skin as normal in appearance 67% of the time, and having some redness 33% of the time. Slight skin redness can be expected due to the heating of tissue and the increase in local circulation caused by therapeutic ultrasound, and is not considered to be a negative effect.
The sample size of this study, 20 subjects, with each subject using the device three times, means that at a minimum, 95% of all user problems should be found, and the mean percentage is between 98.4% and 99.0% [12] . This demonstrates that the study captured the potential usability issues of this device with a high degree of confidence, and therefore, this feedback is sufficient to assess usability and any residual risk associated with the device.
IV. DISCUSSION
The device was successfully used by 20 subjects over 60 treatments with no negative effects or adverse events. The overall lessons taken from this study are that the device was usable for a layperson, that the vast majority of user experiences were positive, and the majority of user feedback involved making the applicator interface with the bandage easier to handle. The device was successful in providing treatments, and nearly 9 in 10 subjects who tried the device would use it again. The therapeutic ultrasound device was found to be reasonably safe and effective for the intended users, uses, and use environments. The 95% success rate of usage and the methods for collecting data support this conclusion. Any residual risk that remains would not be reduced by modification of the design of the user interface, and is outweighed by the therapeutic benefit derived from the use of the device.
There were several results of this study which suggested the Human Factors Engineering associated with this device could be improved. The study revealed that the current method of attachment of the applicator to the coupling bandage may not be optimal, as nearly 40% of users had difficulty with the insertion forces. To accommodate those users, future design revisions will lessen the force required to clip the applicator into the bandage. The decrease in insertion forces will also mean that the ultrasound coupling media is subject to less pressure, and will not be as messy, which was another reported issue with the device. Additionally, long term research is looking at the use of alternative coupling media that will completely eliminate the media being expelled. Human Factors Engineering is inherently an iterative process, where a man-machine interface is rationally designed, put into practice, and then modified based on user feedback. Obtaining that feedback directly, early, and as often as possible will streamline this process.
While there are areas for improvement, the study validated that the device can be safely and successfully used and operated by intended users. Long duration, low intensity therapeutic ultrasound holds the promise of providing nonpharmaceutical pain relief to patients suffering from a broad range of conditions. This study demonstrates that the wearable ultrasound device is accessible to a general audience, and that the technology will fulfill that promise.
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